Clinical Trial Imaging Market
According to Intent Market Research, the Clinical Trial Imaging Market is expected to grow from USD 1.2 billion in 2023 at a CAGR of 7.6% to touch USD 2.0 billion by 2030. The clinical trial imaging market is dominated by key players such as BioTelemetry, ICON plc, IXICO, Calyx Group, Biomedical Systems Corporation, and Medpace.